期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 120, 期 4, 页码 963-972出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI41350
关键词
-
资金
- NIH [NIH-HD-16229, NIH-HD-16272, NIH-HD-07945]
- Burroughs Wellcome Career Award in the Biomedical Sciences
- Dan L. Duncan Cancer Center
- Caroline Weiss Law Fund for Molecular Medicine
The classical view of ovarian follicle development is that it is regulated by the hypothalamic-pituitary-ovarian axis, in which gonadotropin-releasing hormone (GnRH) controls the release of the gonadotropic hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exert both negative and positive regulatory effects on GnRH secretion. More recent studies in mice and humans indicate that many other intra-ovarian signaling cascades affect follicular development and gonadotropin action in a stage- and context-specific manner. As we discuss here, mutant mouse models and clinical evidence indicate that some of the most powerful intra-ovarian regulators of follicular development include the TGF-beta/SMAD, WNT/FZD/beta-catenin, and RAS/ERK1/2 signaling pathways and the FOXO/FOXL2 transcription factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据